MMIT’s P&T Persectives on Neutropenia reviewed Rolontis® (eflapegrastim), a new long-acting rhG-CSF therapy for patients with chemotherapy induced neutropenia.
Be the first to know about new arrivals and promotions
Reducing Risk: 5 Steps for a Fearless Launch
